Amplify Weight Loss Drug & Treatment ETF (THNR) Chart & Stock Price History $21.99 +0.08 (+0.37%) As of 04:10 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Amplify Weight Loss Drug & Treatment ETF Stock Price Performance The Amplify Weight Loss Drug & Treatment ETF (THNR) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has decreased 15.49%, with a year-to-date return of -2.48%. In the past month, the fund has decreased 3.89%, reflecting recent market activity. As of the latest close, Amplify Weight Loss Drug & Treatment ETF traded at $21.91 with a market cap of $2.85 million and volume of 40,733 shares. Receive THNR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amplify Weight Loss Drug & Treatment ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.61%1 Month Performance-3.89%3 Month Performance+1.99%Year-To-Date Performance-2.48%1 Year Performance-15.49% THNR Stock Chart for Friday, August, 8, 2025 THNR Chart by TradingView Amplify Weight Loss Drug & Treatment ETF Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$22.28$21.91-1.66%$21.97$21.7040,733 shs$2.85 million08/06/2025$22.80$22.28-2.28%$22.99$22.232,651 shs$2.90 million08/05/2025$22.85$22.80-0.22%$22.81$22.791,304 shs$2.96 million08/04/2025$22.58$22.85+1.20%$22.86$22.612,197 shs$2.97 million08/01/2025$22.45$22.58+0.58%$22.58$22.451,303 shs$2.94 million07/31/2025$22.92$22.45-2.05%$22.90$22.45736 shs$2.92 million07/30/2025$23.11$22.92-0.82%$23.15$22.921,147 shs$2.98 million07/29/2025$23.64$23.11-2.24%$23.65$22.8422,633 shs$3.00 million07/28/2025$23.85$23.64-0.88%$24.02$23.641,059 shs$3.07 million07/25/2025$23.75$23.85+0.42%$23.85$23.741,973 shs$3.10 million Get the Latest News and Ratings for THNR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amplify Weight Loss Drug & Treatment ETF and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$23.71$23.75+0.17%$23.75$23.66592 shs$3.09 million07/23/2025$23.01$23.71+3.04%$23.71$23.572,312 shs$3.08 million07/22/2025$22.64$23.01+1.63%$23.01$22.82411 shs$2.99 million07/21/2025$22.75$22.64-0.48%$22.69$22.64421 shs$2.94 million07/18/2025$22.86$22.75-0.48%$22.85$22.75751 shs$2.96 million07/17/2025$22.99$22.86-0.57%$22.99$22.86767 shs$2.97 million07/16/2025$22.79$22.99+0.88%$22.99$22.98493 shs$2.99 million07/15/2025$23.16$22.79-1.60%$22.79$22.79249 shs$2.96 million07/14/2025$22.97$23.16+0.83%$23.20$23.162,251 shs$3.01 million07/11/2025$23.28$22.97-1.33%$22.97$22.871,181 shs$2.99 million07/10/2025$23.11$23.28+0.74%$23.37$23.28747 shs$3.03 million07/09/2025$22.88$23.11+1.01%$23.11$22.991,164 shs$3.00 million07/08/2025$22.76$22.88+0.53%$23.00$22.86564 shs$2.97 million07/07/2025$22.98$22.76-0.96%$22.76$22.72476 shs$2.96 million Related Companies ProShares Ultra Nasdaq Cloud Computing ETF Stock Chart KraneShares 100% KWEB Defined Outcome Through January 2026 ETF Stock Chart Tema Luxury ETF Stock Chart First Trust Bloomberg R&D Leaders ETF Stock Chart Morningstar US Small Growth Stock Chart Global X Education ETF Stock Chart AdvisorShares Hotel ETF Stock Chart Westwood LBRTY Global Equity ETF Stock Chart SPDR MSCI USA Climate Paris Aligned ETF Stock Chart Kelly CRISPR & Gene Editing Technology ETF Stock Chart Receive THNR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amplify Weight Loss Drug & Treatment ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:THNR) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
